Global market for multiple sclerosis disease-modifying products to reach $14.2 billion by 2018
Disease-modifying agents to treat multiple sclerosis (MS) are currently one of the largest classes of pharmaceutical products by sales in the U.S. and throughout the world. The total worldwide market for MS disease-modifying therapies is expected to reach nearly $14.2 billion by the end of 2018. The U.S. will be the primary market for most… Read More Global market for multiple sclerosis disease-modifying products to reach $14.2 billion by 2018